Skip to main content

Advertisement

Log in

La terapia farmacologica delle ernie discali

Pharmacological treatment of slipped disc

  • Published:
Archivio di Ortopedia e Reumatologia

Abstract

Pain due to slipped disc can reach a very high intensity and needs a suitable pharmacological treatment.

An hypothetical step-up treatment of musculoskeletal pain addresses symptoms caused by slipped disc. This treatment, according to WHO guidelines, should start with non-pharmacological treatments followed by or associated with acetaminophene alone or associated to other agents. If there is no response, it is possible to use NSAIDs at increasing doses, alone or associated, local or systemic steroids and, in non-responder cases, weak or strong opioids alone or associated with other medication. Various pharmacological therapies are analyzed (analgesics, NSAIDs, steroids, opioids, anticonvulsivants and vitaminic complexes) showing indications, contraindications and treatment schemes.

Pharmacological therapy in slipped disc is rich but also insidious. Using effective therapies needs a lot of experience. A correct diagnosis and a rapid change in therapeutical strategy according to patient response are mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Bibliografia

  1. American Pain Society (2006) The use of opioids for the treatment of chronic pain. www.ampainsoc.org/advocacy/opioids.htm

  2. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43:1905–1915

    Article  Google Scholar 

  3. Pendleton A, Arden N, Dougados M et al (2000) EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59:936–944

    Article  PubMed  CAS  Google Scholar 

  4. Punzi L, Doherty M, Zhang W et al (2006) Italian consensus on EULAR recommendations 2005 for the management of hip osteoarthritis. Reumatismo 58:301–309

    PubMed  CAS  Google Scholar 

  5. Silverfield JC, Kamin M, Wu SC, Rosenthal N; CAPSS-105 Study Group (2002) Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 24:282–297

    Article  PubMed  CAS  Google Scholar 

  6. Todesco S, Gambari PF (2003) Malattie reumatiche. McGraw-Hill, Milano

    Google Scholar 

  7. DeBisschop M (2003) What are the risks of long-term NSAIDs and COX-2 inhibitors? J Fam Pract 52:199–200

    PubMed  Google Scholar 

  8. Brater DC (2002) Anti-inflammatory agents and renal function. Semin Arthritis Rheum 32[3 Suppl 1]:33–42

    Article  PubMed  CAS  Google Scholar 

  9. Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520–1528

    Article  PubMed  CAS  Google Scholar 

  10. Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247–1255

    Article  PubMed  CAS  Google Scholar 

  11. Cannon CP, Curtis SP, FitzGerald GA et al (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 368:1771–1781

    Article  PubMed  CAS  Google Scholar 

  12. DeMaria AN, Weir MR (2003) Coxibs-beyond the GI tract: renal and cardiovascular issues. J Pain Symptom Manage 25[2 Suppl]:41–49

    Article  Google Scholar 

  13. Lanas A, García-Rodríguez LA, Arroyo MT et al (2006) Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55:1731–1738

    Article  PubMed  CAS  Google Scholar 

  14. Catella-Lawson F, Reilly MP, Kapoor SC et al (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817

    Article  PubMed  CAS  Google Scholar 

  15. FitzGerald GA (2002) Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations. Am J Cardiol 89[Suppl A]:26–32

    Article  Google Scholar 

  16. Schiavon F (2007) I farmaci oppioidi nel trattamento del dolore in reumatologia. Reumatismo 59[Suppl]:3–12

    Google Scholar 

  17. McQuay H, Moore A (1998) An evidence-based resource for pain relief. Oxford University Press, Oxford

    Google Scholar 

  18. Kalso E, Edwards JE, Moore RA, McQuay HJ (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112:372–380

    Article  PubMed  CAS  Google Scholar 

  19. Turk DC, Brody MC, Okifuji EA (1994) Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 59:201–208.

    Article  PubMed  CAS  Google Scholar 

  20. McPhillips-Tangum CA, Cherkin DC, Rhodes LA, Markham C (1998) Reasons for repeated medical visits among patients with chronic back pain. J Gen Intern Med 13:289–295

    Article  PubMed  CAS  Google Scholar 

  21. Hutchinson K, Moreland AM, de C Williams AC et al (2007) Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners. Eur J Pain 11:93–98

    Article  PubMed  Google Scholar 

  22. Breivik H (2005) Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain 9:127–130

    Article  PubMed  CAS  Google Scholar 

  23. Cluff R, Mehio AK, Cohen SP et al (2002) The technical aspects of epidural steroid injections: a national survey. Anesth Analg 95:403–408

    Article  PubMed  Google Scholar 

  24. Kim H, Lee SH, Kim MH (2007) Multislice CT fluoroscopy-assisted cervical transforaminal injection of steroids: technical note. J Spinal Disord Tech 20:456–461

    Article  PubMed  Google Scholar 

  25. Wiffen P, Collins S, McQuay H et al (2005) Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 3:CD001133

    PubMed  Google Scholar 

  26. Lesser H, Sharma U, LaMoreaux L, Poole RM (2004) Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63:2104–2110

    PubMed  CAS  Google Scholar 

  27. Dworkin RH, Corbin AE, Young JP Jr et al (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274–1283

    PubMed  CAS  Google Scholar 

  28. Bast A, Haenen GR (2003) Lipoic acid: a multifunctional antioxidant. Biofactors 17:207–213

    Article  PubMed  CAS  Google Scholar 

  29. Ou P, Tritschler HJ, Wolff SP (1995) Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 50:123–126

    Article  PubMed  CAS  Google Scholar 

  30. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV (2005) Lipoic acid improves glucose utilisation and prevents protein glycation and AGE formation. Pharmazie 60:772–775

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Paresce, E., Murgo, A., Pisoni, L. et al. La terapia farmacologica delle ernie discali. Arch Ortop Reumatol 119, 10–12 (2008). https://doi.org/10.1007/s10261-008-0242-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10261-008-0242-6

Navigation